Currently, gene editing is attracting attention as a therapeutic strategy for DMD because of the restoration of the dystrophin reading frame in more than 40% of all patients with DMD [56,57,58,59,60,61,62,63]. Here, DMD is linked to Duchenne muscular dystrophy.